A Cancer Treatment That Does More Than Scientists Thought

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

Gene and Cell Therapy Spotlighted in Resurrection LA Premiere May 1–7 as San Rocco Therapeutics Advances Toward a Cure

I am deeply humbled by the decades of support from people around the world. It is an honor to share this painful yet ...
Fierce Biotech

In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient

A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...
Healio

FDA to ‘carefully shepherd’ CAR T-cell therapy trials in autoimmune, rheumatic disease

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...
The American Journal of Managed Care

In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients

In vivo CAR T-cell therapy could revolutionize cancer treatment by bypassing traditional manufacturing, reducing costs, and minimizing adverse events. Kelonia Therapeutics' KLN-1010 has shown ...

Inside a cell therapy manufacturing facility: How Iovance turns a patient’s immune cells into treatment

Iovance chose Philadelphia for its manufacturing operations because of the region's proximity to airports and history of ...
New Scientist on MSN

CAR T-cell therapy takes woman from bedridden to 'perfectly fine'

A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
News-Medical.Net

CAR T therapy induces remission in multiple autoimmune diseases

For the first time, scientists have used a cutting-edge cell therapy called CAR-T to treat a patient with three different ...

Could gene edits solve obstacles to treatment for the most common types of cancer?

Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...
Fierce Pharma

FDA extends review of Orca Bio’s novel cell therapy for blood cancers

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...
Regulatory Affairs Professionals Society

Expert: FDA, industry still wary of enrolling patients in early cell and gene therapy trials

US Food and Drug Administration (FDA) officials credited recent advancements in regulatory science and flexibilities with ...

Stem Cell Therapy for Neurological Disorders at Sharlin Health in Ozark, MO

Sharlin Health and Neurology Introduces New Stem Cell Therapy Program for Neurological Disorders in Ozark, MO Ozark, ...